Skip to content

A study comparing Yavadi cream and Yavadi herbal paste for the treatment of facial dark patches (melasma) in patients

A Randomized Comparative Clinical Study to evaluate efficacy of Local application of Yavadi cream and Yavadi lepa in the Treatment of Vyanga w.s.r to Melasma - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/02/104877
Enrollment
120
Registered
2026-02-26
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L811- Chloasma

Interventions

None listed

Sponsors

DR PRIYANKA ARUN MHATRE
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Subjects aged 30 to 60 years will be included. 2. Diagnosed cases of Vyanga (Melasma) based on classical and clinical criteria will be included. 3. Presence of facial hyperpigmented patches consistent with melasma will be included. 4. Both males and females will be included. 5. Subject is willing to participate and follow protocol will be included.

Exclusion criteria

Exclusion criteria: 1. Pregnant and lactating women will be excluded. 2. Other facial skin disorders (eg.lichen planus,post inflammatory hyperpigmentation) will be excluded. 3. Known Thyroid dysfunction case will be excluded. 4. Known Addisons disease will be excluded. 5. Recent use (within 3 months) of hormonal therapy, cosmetic procedures will be excluded.

Design outcomes

Primary

MeasureTime frame
Reduction in mMASI scoreimprovement in Taylor hyperpigmentation scale , dermoscopic changes, percentage improvement,.Timepoint: 0,10th,20th,30th day

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactDR NEENA DAMLE

Padmashree Dr D.Y. Patil Deemed to be University, School of Ayurveda

neena.damle@dypatil.edu9769028549

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026